Open access · CC-BY
via OpenAlex
Transdiagnostic evaluation of epigenetic age acceleration and burden of psychiatric disorders
Natan Yusupov, Linda Dieckmann, Mira Erhart, Susann Sauer, Monika Rex‐Haffner, Johannes Kopf‐Beck, Tanja Maria Brückl, Darina Czamara, Elisabeth B. Binder
Neuropsychopharmacology · 2023 · ▲ 29 citations
Abstract
Different psychiatric disorders as well as exposure to adverse life events have individually been associated with multiple age-related diseases and mortality. Age acceleration in different epigenetic clocks can serve as biomarker for such risk and could help to disentangle the interplay of psychiatric comorbidity and early adversity on age-related diseases and mortality. We evaluated five epigenetic clocks (Horvath, Hannum, PhenoAge, GrimAge and DunedinPoAm) in a transdiagnostic psychiatric sample using epigenome-wide DNA methylation data from peripheral blood of 429 subjects from two studies at the Max Planck Institute of Psychiatry. Burden of psychiatric disease, represented by a weighted score, was significantly associated with biological age acceleration as measured by GrimAge and DunedinPoAm (R2-adj. 0.22 and 0.33 for GrimAge and DunedinPoAm, respectively), but not the other investigated clocks. The relation of burden of psychiatric disease appeared independent of differences in socioeconomic status and medication. Our findings indicate that increased burden of psychiatric disease may associate with accelerated biological aging. This highlights the importance of medical management of patients with multiple psychiatric comorbidities and the potential usefulness of specific epigenetic clocks for early detection of risk and targeted intervention to reduce mortality in psychiatric patients.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41386-023-01579-3
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Yusupov, N., Dieckmann, L., Erhart, M., Sauer, S., Rex‐Haffner, M., Kopf‐Beck, J., Brückl, T.M., Czamara, D., & Binder, E.B. (2023). Transdiagnostic evaluation of epigenetic age acceleration and burden of psychiatric disorders. <em>Neuropsychopharmacology</em>. https://doi.org/10.1038/s41386-023-01579-3
Vancouver
Yusupov N, Dieckmann L, Erhart M, Sauer S, Rex‐Haffner M, Kopf‐Beck J, et al. Transdiagnostic evaluation of epigenetic age acceleration and burden of psychiatric disorders. Neuropsychopharmacology. 2023. doi:10.1038/s41386-023-01579-3.
BibTeX
@article{natan2023Transd,
title = {Transdiagnostic evaluation of epigenetic age acceleration and burden of psychiatric disorders},
author = {Natan Yusupov and Linda Dieckmann and Mira Erhart and Susann Sauer and Monika Rex‐Haffner and Johannes Kopf‐Beck and Tanja Maria Brückl and Darina Czamara and Elisabeth B. Binder},
journal = {Neuropsychopharmacology},
year = {2023},
doi = {10.1038/s41386-023-01579-3},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
medRxiv 2024
Preprint · OA
Prenatal exposure to genocide accelerates epigenetic aging as measured in second-generation clocks among young adults
Blood 2022
Citation only
Bloom Syndrome Patients Display Accelerated Epigenetic Aging in Blood Lymphocytes
Epigenomics 2026
Citation only
Epigenetic age acceleration is not strongly associated with cardiorespiratory fitness in heart failure: a pilot study.
Ageing Research Reviews 2021
Open access · CC-BY
A systematic review of biological, social and environmental factors associated with epigenetic clock acceleration
Journal of neurology, neurosurgery, and psychiatry 2026
Citation only
Epigenetic ageing and the risk of Parkinson's disease.
Current Alzheimer Research 2021
Preprint · OA